Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

Clinical trial NCT06394232 · RECRUITING

Trial details

NCT number: NCT06394232
Sponsor: Eyestem Research Pvt. Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Retinal Disease Macular Degeneration Age-Related Macular Degeneration Geographic Atrophy Eye Diseases

Start date: 2024-06-04
Primary completion: 2025-04-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.